Share

Horizon Pharma CEO explains stock surge after positive eye drug trial

CNBC's "Power Lunch" is joined by Horizon Pharma CEO Timothy Walbert to talk about the positive trial for a new eye drug and the company's outlook.
04:13
Thu, Feb 28 20193:16 PM EST